Presentation Pandemonium = 30% Pop

Aegerion Pharmaceuticals  (NASDAQ: AEGR  ) is up 30%, thanks to a presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference. Analysts have literally rushed out and threw upgrades at the stock after the company announced a price hike for HoFH drug Juxtapid.

In this video, health-care analyst David Williamson discusses what these events mean for investors in Aegerion, and also for its competitors.

Another health-care topic that investors need to keep up on is Obamacare, as the law will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more. 


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2437127, ~/Articles/ArticleHandler.aspx, 4/18/2014 11:15:39 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement